C

CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765

Watchlist Manager
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Watchlist
Price: 27.26 CNY -1.73% Market Closed
Market Cap: 72.9B CNY
Have any thoughts about
CSPC Innovation Pharmaceutical Co Ltd?
Write Note
CSPC Innovation Pharmaceutical Co Ltd
/
Income Statement
/
Income to Minority Interest

CSPC Innovation Pharmaceutical Co Ltd
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CSPC Innovation Pharmaceutical Co Ltd
Income to Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Income to Minority Interest
¥186.1m
CAGR 3-Years
810%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Income to Minority Interest
-¥34.5m
CAGR 3-Years
-10%
CAGR 5-Years
-40%
CAGR 10-Years
-61%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income to Minority Interest
¥5.1m
CAGR 3-Years
-35%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income to Minority Interest
-¥31.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CSPC Innovation Pharmaceutical Co Ltd
Glance View

Market Cap
72.9B CNY
Industry
Pharmaceuticals

CSPC Innovation Pharmaceutical Co., Ltd., founded in 1997, has emerged as a prominent player in China's pharmaceutical landscape, with a mission to create innovative healthcare solutions. As a subsidiary of CSPC Pharmaceutical Group, the company is committed to research and development, focusing on both generic and specialty pharmaceuticals. By leveraging advanced technologies and a robust pipeline of drug candidates, CSPC Innovation has positioned itself as a pioneer in addressing critical healthcare needs in areas such as oncology, cardiovascular diseases, and infectious diseases. Investors can take note of its impressive track record in developing new drugs, attracting substantial investments through strategic partnerships and collaborations, which bolster its ability to compete in a rapidly evolving market. As the global demand for new therapies escalates, CSPC Innovation is not only positioned for growth within the domestic market but also aims for international expansion. The company's emphasis on quality and compliance with international pharmaceutical standards enhances its credibility and facilitates entry into foreign markets. With a strong balance sheet and a commitment to innovation, CSPC Innovation is poised to capture opportunities in the vast healthcare sector, making it an appealing option for investors looking to participate in the burgeoning global pharmaceutical industry. The synthesis of cutting-edge research, a dedicated workforce, and a growing portfolio of patented drugs contributes to its potential for sustainable growth, ultimately enhancing shareholder value.

Intrinsic Value
12.16 CNY
Overvaluation 55%
Intrinsic Value
Price
C
What is Intrinsic Value?

See Also

What is CSPC Innovation Pharmaceutical Co Ltd's Income to Minority Interest?
Income to Minority Interest
186.1m CNY

Based on the financial report for Sep 30, 2024, CSPC Innovation Pharmaceutical Co Ltd's Income to Minority Interest amounts to 186.1m CNY.

What is CSPC Innovation Pharmaceutical Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 3Y
810%

The average annual Income to Minority Interest growth rates for CSPC Innovation Pharmaceutical Co Ltd have been 810% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.